Dr. Colleen Darnell, MD
Claim this profileSaint Elizabeth Medical Center South
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
16 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
Stage II
2Non-Small Cell Lung Cancer
Stage III
Stage IV
EGFR negative
Affiliated Hospitals
Clinical Trials Colleen Darnell, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
TTFields + Pembrolizumab
for Lung Cancer
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T System with IV pembrolizumab in subjects previously untreated for advanced or metastatic, PD-L1 positive non-small cell lung cancer (NSCLC). The primary objective is to evaluate the progression-free survival (PFS) by RECIST 1.1 in subjects with TPS ≥1 percent, 1L metastatic/current advanced NSCLC treated with TTFields concomitant with pembrolizumab compared to those treated with pembrolizumab alone. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields) to the region of the malignant tumor, by means of surface, insulated electrode arrays.
Recruiting1 award Phase 28 criteria
More about Colleen Darnell, MD
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Colleen Darnell, MD has experience with
- NovoTTF-200T
- Nivolumab
- Ipilimumab
- Durvalumab
- Docetaxel
- Gemcitabine
Breakdown of trials Colleen Darnell, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Small Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Colleen Darnell, MD specialize in?
Colleen Darnell, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Colleen Darnell, MD currently recruiting for clinical trials?
Yes, Colleen Darnell, MD is currently recruiting for 2 clinical trials in Edgewood Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Colleen Darnell, MD has studied deeply?
Yes, Colleen Darnell, MD has studied treatments such as NovoTTF-200T, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Colleen Darnell, MD?
Apply for one of the trials that Colleen Darnell, MD is conducting.
What is the office address of Colleen Darnell, MD?
The office of Colleen Darnell, MD is located at: Saint Elizabeth Medical Center South, Edgewood, Kentucky 41017 United States. This is the address for their practice at the Saint Elizabeth Medical Center South.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.